Next Article in Journal
Long Non-Coding RNA Myoparr Regulates GDF5 Expression in Denervated Mouse Skeletal Muscle
Next Article in Special Issue
Asymmetric Inheritance of Cell Fate Determinants: Focus on RNA
Previous Article in Journal
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
Previous Article in Special Issue
Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease
Open AccessArticle

Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients

1
MIGAL Galilee Research Institute, Kiryat Shmona 1101602, Israel
2
Tel Hai Academic College, Upper Galilee 1220800, Israel
3
Department of Internal Medicine A, Galilee Medical Center, Nahariya 89, Israel
4
Department of Gastroenterology, Galilee Medical Center, Nahariya 89, Israel
5
Director, Galilee Medical Center, Nahariya 89, Israel
6
The Azrieli Faculty of Medicine, Bar Ilan University, Safed 5290002, Israel
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2019, 5(2), 32; https://doi.org/10.3390/ncrna5020032
Received: 24 January 2019 / Revised: 29 March 2019 / Accepted: 4 April 2019 / Published: 5 April 2019
(This article belongs to the Special Issue Non-Coding RNAs: Variations and Disease)
MicroRNAs play functional roles in the etiology of type 2 diabetes mellitus (T2DM) and complications, and extracellular microRNAs have attracted interest as potential biomarkers of these conditions. We aimed to identify a set of plasma microRNAs, which could serve as biomarkers of T2DM and complications in a mixed Israeli Arab/Jewish patient sample. Subjects included 30 healthy volunteers, 29 early-stage T2DM patients, and 29 late-stage T2DM patients with renal and/or vascular complications. RNA was isolated from plasma, and the levels of 12 candidate microRNAs were measured by quantitative reverse transcription and polymerase chain reaction (qRT-PCR). MicroRNA levels were compared between the groups and correlated to clinical measurements, followed by stepwise regression analysis and discriminant analysis. Plasma miR-486-3p and miR-423 were respectively up- and down-regulated in T2DM patients compared to healthy controls. MiR-28-3p and miR-423 were up-regulated in patients with complicated T2DM compared to early T2DM, while miR-486-3p was down-regulated. Combined, four microRNAs (miR-146a-5p, miR-16-2-3p, miR-126-5p, and miR-30d) could distinguish early from complicated T2DM with 77% accuracy and 79% sensitivity. In male patients only, the same microRNAs, with the addition of miR-423, could distinguish early from complicated T2DM with 83.3% accuracy. Furthermore, plasma microRNA levels showed significant correlations with clinical measurements, and these differed between men and women. Additionally, miR-183-5p levels differed significantly between the ethnic groups. Our study identified a panel of specific plasma microRNAs which can serve as biomarkers of T2DM and its complications and emphasizes the importance of sex differences in their clinical application. View Full-Text
Keywords: microRNAs; extracellular; blood-borne; biomarkers; diabetes mellitus; complications; sex differences microRNAs; extracellular; blood-borne; biomarkers; diabetes mellitus; complications; sex differences
Show Figures

Figure 1

MDPI and ACS Style

Meerson, A.; Najjar, A.; Saad, E.; Sbeit, W.; Barhoum, M.; Assy, N. Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients. Non-Coding RNA 2019, 5, 32.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop